(1)
Siegel , D. .; Murphy , C.; Wangsness, K.; Perry , A. .; Smith , I. . Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma. J of Skin 2022, 6, 109-121.